Pathstone Family Office’s Ascendis Pharma ASND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-4,484
| Closed | -$523K | – | 1211 |
|
|
2022
Q4 | $523K | Sell |
4,484
-44
| -1% | -$5.14K | ﹤0.01% | 1075 |
|
|
2022
Q3 | $468K | Buy |
+4,528
| New | +$468K | ﹤0.01% | 1096 |
|
|
2021
Q1 | – | Sell |
-70
| Closed | -$12K | – | 687 |
|
|
2020
Q4 | $12K | Hold |
70
| – | – | ﹤0.01% | 829 |
|
|
2020
Q3 | $11K | Buy |
+70
| New | +$11K | ﹤0.01% | 584 |
|